Navigation Links
At Nearly $120 Million, The Hepatitis C Drug Market in Brazil is Among the Largest Emerging Pharmaceutical Markets for the Disease
Date:12/8/2009

WALTHAM, Mass., Dec. 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that at approximately $120 million, the hepatitis C virus drug market in Brazil is among the largest emerging pharmaceutical markets for the disease. In 2008, sales of hepatitis C virus drugs in Brazil amounted to about 16 percent of the U.S. hepatitis C virus drug market (in comparison, China's and India's markets amounted to less than 10 percent each of the U.S. market). Brazil's larger market size can be attributed to the country's well established public health care system that pays for the cost of drug therapy for eligible patients.

The new Emerging Markets report entitled Hepatitis C Virus in Brazil forecasts that emerging hepatitis C virus therapies in Brazil will reach combined sales of nearly $15 million by 2013. Given Brazil's low regulatory hurdles (additional domestic clinical trials are not required) and relatively sizeable target segments, at least two novel agents--telaprevir (Vertex Pharmaceuticals/Johnson & Johnson/Mitsubishi Tanabe's VX-950/MP-424) and albinterferon-alpha-2b (Novartis/Human Genome Sciences' Albuferon)--are expected to launch towards the end of the 2008-2013 forecast period.

"Emerging therapies such as telaprevir and albinterferon-alpha-2b will find a role in the hepatitis C virus drug market in Brazil as second- and third-line therapies given the drawbacks and limitations of current treatment options and physicians' enthusiasm for novel approaches," stated Kate Hohenberg, principal director of Emerging Markets at Decision Resources.

The new report contains primary research of physicians and epidemiology study in key pharmaceutical markets of Brazil--Rio de Janeiro, Sao Paulo, Brasilia and Belo Horizonte.

About Emerging Markets Reports

Decision Resources offers a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis. Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians' practices.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.


For more information, contact:
Gisselle Morales                             Elizabeth Marshall
Decision Resources                           Decision Resources, Inc.
781-296-2691                                 781-296-2563
gmorales@dresources.com                      emarshall@dresources.com


SOURCE Decision Resources


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. European Small-Joint Reconstructive Implant Market to Nearly Double to $360 Million By 2014
2. Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9,000 Patients Annually
3. Gaining Too Much Weight During Pregnancy Nearly Doubles Risk of Having a Heavy Baby
4. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
5. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
6. ACORN Continues Success in Oncology Data Warehousing With Accumulation of Nearly 50 Million Data Observations
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors Visits
9. Gene Therapy Provides Vision to People who Were Nearly Blind
10. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
11. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  Economic growth in the United ... and supply management executives in their December 2016 Semiannual ... economic recovery that began in mid-2009, as indicated in ... ® . The manufacturing sector is optimistic about ... 16 manufacturing industries, and the non-manufacturing sector indicates that ...
(Date:12/8/2016)... According to a new market research report "Wearable Medical Devices Market ... Use (Sports, Fitness, RPM), Type (Smart watch, Patch), Distribution Channel (Pharmacy, Hypermarket) ... of value, is projected to reach 12.14 Billion by 2021 from USD ... period. Continue Reading ... ...
(Date:12/8/2016)... Calif. , Dec. 8, 2016  Agenovir ... to develop novel antiviral therapeutics, today announced that ... chief executive officer and a member of the ... incredibly experienced executive with a deep background in ... Quake, D.Phil., founder of Agenovir, co-president of Chan ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... ... announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to ... Medical Informatics . , Results of the comparative usability study demonstrate that a ...
(Date:12/8/2016)... ... ... With the increasing demand for dental implants, the National Association of Dental ... dentists and patients about the safety issues related to dental restorations. According to the ... is projected to reach $6.4 billion in 2018 with more than 30 million Americans ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... its innovative Unified Instance Manager architecture, meeting the needs of multichannel growth ... optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... California Senate ... medical payments per workers’ compensation claim in 2013 and 2014, according to CompScope™ ... Research Institute (WCRI) . , According to the study, medical payments per claim in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Dickinson Insurance and ... headquartered in Little Rock, has initiated a charity drive to provide support and ... to End Senior Hunger, Arkansas ranks first in senior hunger statewide, third in ...
Breaking Medicine News(10 mins):